Gilead, working on its own remdesivir ramp-up, scouts licensing partners for global production

6th May 2020 Uncategorised 0

Gilead Sciences can only produce so much of its newly authorized COVID-19 med remdesivir, so it’s scouting other companies to bolster global supply. The Big Biotech is in licensing talks with major players, including generics makers in India and Pakistan, to produce enough of the antiviral for countries around the world.

More: Gilead, working on its own remdesivir ramp-up, scouts licensing partners for global production
Source: fierce